MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ijlh.70065

Медицинская библиотека · International journal of laboratory hematology · 2026

Clinicopathological and Immunophenotypic Analysis of Early T-Cell Precursor Acute Lymphoblastic Leukemia With Application of the Tokyo Children's Cancer Study Group Flow Cytometry Scoring System.

Ravi Soundarya, Kannan Narasimhapriyan, Manivannan Prabhu, Kar Rakhee, Kayal Smita

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a distinct subtype of T-ALL defined by an immature immunophenotype and unique molecular features. It is often associated with chemoresistance and poor outcomes. Accurate recognition is crucial for therapy optimization and consideration of hematopoietic stem cell transplantation. This study evaluated the Tokyo Children's Cancer Study Group (TCCSG) six-marker flow cytometric scoring system in identifying ETP-ALL and assessed its clinicopathological features and treatment outcomes.

METHODS

All consecutive T-ALL cases diagnosed between 2019 and 2023 were retrospectively analyzed. Clinical, immunophenotypic, and treatment-related data were compared between ETP-ALL and non-ETP-ALL subgroups. The TCCSG six-marker scoring system (CD34, HLA-DR, CD8, CD5, CD13, CD33) was applied, and receiver operating characteristic curve analysis determined the optimal cutoff for diagnosis.

RESULTS

Among 104 T-ALL cases, 25 (24.1%) were classified as ETP-ALL. ETP-ALL was more common in adults (> 18 years; 72.0% vs. 48.1%; p = 0.037). Compared with non-ETP-ALL, patients showed lower leukocyte counts (< 100 × 109/L), fewer peripheral blasts, and higher platelet counts (p < 0.05). At end-of-induction (EOI), complete remission rates were lower in ETP-ALL (73.3% vs. 96.6%; p = 0.014), though no significant differences were observed in EOI measurable residual disease, consolidation response, or survival between the groups. A cutoff score ≥ 3 using the TCCSG system yielded 88% sensitivity and 94.9% specificity (AUC = 0.986; p = 0.0001).

CONCLUSION

ETP-ALL represents a biologically distinct T-ALL subtype with inferior early treatment responses. The TCCSG six-marker scoring system is reliable, accurate, and practical for routine diagnosis, particularly in resource-limited settings.

Для цитирования: Ravi Soundarya, Kannan Narasimhapriyan, Manivannan Prabhu, Kar Rakhee, Kayal Smita. Clinicopathological and Immunophenotypic Analysis of Early T-Cell Precursor Acute Lymphoblastic Leukemia With Application of the Tokyo Children's Cancer Study Group Flow Cytometry Scoring System.. International journal of laboratory hematology. 2026. DOI: 10.1111/ijlh.70065.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.